The effect of gender on emotion perception in schizophrenia and bipolar disorder.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 17803756)

Published in Acta Psychiatr Scand on October 01, 2007

Authors

A Vaskinn1, K Sundet, S Friis, C Simonsen, A B Birkenaes, J A Engh, H Jónsdóttir, P A Ringen, S Opjordsmoen, O A Andreassen

Author Affiliations

1: Institute of Psychiatry, University of Oslo, Norway. anja.vaskin@medisin.uio.no

Articles by these authors

Cancer risk in users of calcium channel blockers. Hypertension (1997) 3.30

Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer (2003) 2.43

Copy number variations of chromosome 16p13.1 region associated with schizophrenia. Mol Psychiatry (2009) 2.29

Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology (1998) 2.19

Review of validation studies of the Edinburgh Postnatal Depression Scale. Acta Psychiatr Scand (2001) 2.08

Analysis of hepatitis C virus capsid, E1, and E2/NS1 proteins expressed in insect cells. Virology (1993) 1.92

Autoimmune disease and risk for Parkinson disease: a population-based case-control study. Neurology (2009) 1.86

Falling incidence of penis cancer in an uncircumcised population (Denmark 1943-90) BMJ (1995) 1.83

Early detection of psychosis: positive effects on 5-year outcome. Psychol Med (2010) 1.82

Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med (1999) 1.79

Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease. J Neurosci (2000) 1.79

Early detection strategies for untreated first-episode psychosis. Schizophr Res (2001) 1.72

Atypical cancer pattern in patients with Parkinson's disease. Br J Cancer (2005) 1.72

Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia (2011) 1.62

Apolipoprotein E epsilon4 does not modulate amyloid-β-associated neurodegeneration in preclinical Alzheimer disease. AJNR Am J Neuroradiol (2012) 1.57

Polygenic risk score and the psychosis continuum model. Acta Psychiatr Scand (2014) 1.55

Panic disorder in chest pain patients referred for cardiological outpatient investigation. J Intern Med (1999) 1.55

Thrombosis associated with physical restraints. Acta Psychiatr Scand (2001) 1.53

Neuropsychological testing of cognitive impairment in euthymic bipolar disorder: an individual patient data meta-analysis. Acta Psychiatr Scand (2013) 1.52

Cancer following breast reduction surgery in Denmark. Cancer Causes Control (1997) 1.50

Congenital hypothyroidism: no adverse effects of high dose thyroxine treatment on adult memory, attention, and behaviour. Arch Dis Child (2005) 1.49

Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. J Neurosci (2000) 1.48

Chronic patients in psychiatric institutions: psychopathology, level of functioning and need for care. Acta Psychiatr Scand (1998) 1.45

Early identification of non-remission in first-episode psychosis in a two-year outcome study. Acta Psychiatr Scand (2010) 1.45

Increased oxidative damage to DNA in a transgenic mouse model of Huntington's disease. J Neurochem (2001) 1.45

Fatal myocarditis associated with mesalazine. Lancet (1990) 1.44

Schizophrenia patients with and without post-traumatic stress disorder (PTSD) have different mood symptom levels but same cognitive functioning. Acta Psychiatr Scand (2012) 1.42

Early detection and intervention in first-episode schizophrenia: a critical review. Acta Psychiatr Scand (2001) 1.42

Expanding the range of ZNF804A variants conferring risk of psychosis. Mol Psychiatry (2010) 1.41

Detection of the poor metabolizer-associated CYP2D6(D) gene deletion allele by long-PCR technology. Pharmacogenetics (1995) 1.39

Risk of breast cancer in men with liver cirrhosis. Am J Gastroenterol (1998) 1.39

[How to reduce the number of involuntary admissions?]. Tidsskr Nor Laegeforen (2001) 1.38

Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer (2012) 1.38

Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol (1996) 1.35

Hereditary spastic paraplegia with neurogenic bladder disturbances and syndactylia. Acta Neurol Scand (1980) 1.33

Tracheal cancer in Denmark: a nationwide study. Eur J Cardiothorac Surg (2001) 1.33

Beliefs about medications: measurement and relationship to adherence in patients with severe mental disorders. Acta Psychiatr Scand (2008) 1.30

Full-length viral RNA synthesized in vitro by vesicular stomatitis virus-infected HeLa cell extracts. Virology (1979) 1.26

Depression in postpartum and non-postpartum women: prevalence and risk factors. Acta Psychiatr Scand (2002) 1.25

A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer (2005) 1.23

First-episode schizophrenia with long duration of untreated psychosis. Pathways to care. Br J Psychiatry Suppl (1998) 1.22

Hormone use for menopausal symptoms and risk of breast cancer. A Danish cohort study. Br J Cancer (2005) 1.22

Shortened duration of untreated first episode of psychosis: changes in patient characteristics at treatment. Am J Psychiatry (2001) 1.21

Are GAF scores reliable in routine clinical use? Acta Psychiatr Scand (2007) 1.20

Nonlinear decrease over time in N-acetyl aspartate levels in the absence of neuronal loss and increases in glutamine and glucose in transgenic Huntington's disease mice. J Neurochem (2000) 1.19

Patient satisfaction and treatment environment: a 20-year follow-up study from an acute psychiatric ward. Nord J Psychiatry (2006) 1.15

The Edinburgh Postnatal Depression Scale: validation in a Norwegian community sample. Nord J Psychiatry (2001) 1.12

Neuropsychological test profiles in schizophrenia and non-psychotic depression. Acta Psychiatr Scand (2006) 1.12

Attention profile in schizophrenia compared with depression: differential effects of processing speed, selective attention and vigilance. Acta Psychiatr Scand (2003) 1.11

Methodological pitfalls in early detection studies - the NAPE Lecture 2002. Nordic Association for Psychiatric Epidemiology. Acta Psychiatr Scand (2003) 1.10

Health outcomes in offspring of mothers with breast implants. Pediatrics (1998) 1.09

[Silicone breast implants and breast cancer]. Ugeskr Laeger (1997) 1.07

Neurologic disease among women with breast implants. Neurology (1998) 1.06

Depression during pregnancy and after delivery: a repeated measurement study. J Psychosom Obstet Gynaecol (2004) 1.04

The human amygdala is involved in general behavioral relevance detection: evidence from an event-related functional magnetic resonance imaging Go-NoGo task. Neuroscience (2008) 1.04

Characterization and PCR-based detection of two different hybrid CYP2D7P/CYP2D6 alleles associated with the poor metabolizer phenotype. Pharmacogenetics (1996) 1.04

Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol Psychiatry (2015) 1.03

Use of statins and risk of glioma: a nationwide case-control study in Denmark. Br J Cancer (2013) 1.02

Treatment for Helicobacter pylori infection and risk of Parkinson's disease in Denmark. Eur J Neurol (2012) 1.00

Statins and the risk of acute pancreatitis: a population-based case-control study. Aliment Pharmacol Ther (2006) 1.00

A suggested revision of the Ward Atmosphere Scale. Acta Psychiatr Scand (2003) 1.00

GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00

Cancer risk among users of neuroleptic medication: a population-based cohort study. Br J Cancer (2006) 0.99

Polymorphisms in SREBF1 and SREBF2, two antipsychotic-activated transcription factors controlling cellular lipogenesis, are associated with schizophrenia in German and Scandinavian samples. Mol Psychiatry (2008) 0.99

In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. Hum Gene Ther (1999) 0.98

Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem (1998) 0.98

Social functioning of patients with schizophrenia in high-income welfare societies. Psychiatr Serv (2000) 0.98

Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder. Psychol Med (2007) 0.97

TCF4 sequence variants and mRNA levels are associated with neurodevelopmental characteristics in psychotic disorders. Transl Psychiatry (2012) 0.97

Isolation of a complementary DNA clone encoding a precursor to human eosinophil major basic protein. J Exp Med (1988) 0.97

Unawareness of illness in chronic schizophrenia and its relationship to structural brain measures and neuropsychological tests. Psychiatry Res (2000) 0.96

Use of NSAIDs, smoking and lung cancer risk. Br J Cancer (2007) 0.95

Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. J Neurosurg (2000) 0.95

Predictors of medication adherence in patients with schizophrenia and bipolar disorder. Acta Psychiatr Scand (2012) 0.94

Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer (2005) 0.93

The level of illicit drug use is related to symptoms and premorbid functioning in severe mental illness. Acta Psychiatr Scand (2008) 0.93

Early identification and treatment of schizophrenia: conceptual and ethical considerations. Psychiatry (1996) 0.93

Internal consistency of the Seasonal Pattern Assessment Questionnaire (SPAQ). J Affect Disord (1997) 0.93